4//SEC Filing
Hirsch Andrew 4
Accession 0001662579-25-000021
CIK 0001662579other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:55 PM ET
Size
10.2 KB
Accession
0001662579-25-000021
Insider Transaction Report
Form 4
Hirsch Andrew
DirectorPresident & CEO
Transactions
- Tax Payment
Common Stock
2025-02-14$3.18/sh−12,847$40,853→ 432,515 total - Tax Payment
Common Stock
2025-02-15$3.18/sh−9,370$29,797→ 423,145 total - Award
Common Stock
2025-02-14+223,500→ 445,362 total - Award
Stock Option (Right to Buy)
2025-02-14+335,300→ 335,300 totalExercise: $3.18Exp: 2035-02-13→ Common Stock (335,300 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person.
- [F3]The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001586707
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 4:55 PM ET
- Size
- 10.2 KB